Response Genetics, Inc (RGDXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 3:00 PM EST
Response Genetics Revenue
Response Genetics had revenue of $3.79M in the quarter ending March 31, 2015, a decrease of -2.68%. This brings the company's revenue in the last twelve months to $16.62M, down -8.06% year-over-year. In the year 2014, Response Genetics had annual revenue of $16.72M, down -15.56%.
Revenue (ttm)
16.62M
Revenue Growth
-8.06%
P/S Ratio
n/a
Revenue / Employee
169.55K
Employees
98
Market Cap
39.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2014 | 16.72M | -3.08M | -15.56% |
Dec 31, 2013 | 19.80M | 1.06M | 5.68% |
Dec 31, 2012 | 18.74M | -3.91M | -17.25% |
Dec 31, 2011 | 22.64M | 1.37M | 6.42% |
Dec 31, 2010 | 21.28M | 12.21M | 134.68% |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Dec 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |